Article Details
Retrieved on: 2021-02-20 02:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Immunovant is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of autoimmune diseases.
Article found on: www.salamancapress.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here